Technical Analysis for ATE - Antibe Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 13.46% | |
| Wide Bands | Range Expansion | 13.46% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Stochastic Reached Oversold | Weakness | 11.32% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | 10 days ago |
| Rose Above Previous Day's High | 11 days ago |
| Rose Above 10 DMA | 11 days ago |
| Up 1 ATR | 11 days ago |
| Up 5% | 11 days ago |
Get a Trading Sidekick!
- Earnings date: 2024-02-13
Antibe Therapeutics Inc. Description
Antibe Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation and regenerative medicine. The Company's segments include Antibe Therapeutics, and Citagenix, which is a marketer and distributor of regenerative medicines serving the dental and orthopedic market places. The Company's drug design methodologies involve chemically linking a base drug to its hydrogen sulfide-releasing molecule. Its lead compound, ATB-346, combines hydrogen sulfide with naproxen, which is a non-steroidal anti-inflammatory drug (NSAID). The Company's other products include ATB-352, which is indicated for the treatment of severe acute pain, and ATB-340 is a Gastrointestinal (GI)-safe derivative of aspirin. The Company also offers regenerative medical devices, which include PentOS (CGX-283), CGX-227, CGX-443 and URIST (CGX-276), all of which target bone regeneration, and are indicated for oral and maxillofacial surgery.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Derivative Medicine Pharma Pharmaceutical Chemical Drug Pain Sulfide Leasing RTT Drugs Hydrogen Medical Devices Bone Hydrogen Sulfide Places Surgery Chemical Compounds Inflammation Regenerative Medicine Acute Pain Urist Analgesics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.23 |
| 52 Week Low | 0.15 |
| Average Volume | 165,032 |
| 200-Day Moving Average | 0.658 |
| 50-Day Moving Average | 0.683 |
| 20-Day Moving Average | 0.377 |
| 10-Day Moving Average | 0.321 |
| Average True Range | 0.070 |
| RSI (14) | 35.90 |
| ADX | 47.61 |
| +DI | 24.597 |
| -DI | 39.096 |
| Chandelier Exit (Long, 3 ATRs) | 0.349 |
| Chandelier Exit (Short, 3 ATRs) | 0.361 |
| Upper Bollinger Bands | 0.563 |
| Lower Bollinger Band | 0.192 |
| Percent B (%b) | 0.28 |
| BandWidth | 98.408 |
| MACD Line | -0.117 |
| MACD Signal Line | -0.121 |
| MACD Histogram | 0.0047 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.430 | ||||
| Resistance 3 (R3) | 0.433 | 0.392 | 0.408 | ||
| Resistance 2 (R2) | 0.392 | 0.357 | 0.390 | 0.400 | |
| Resistance 1 (R1) | 0.343 | 0.336 | 0.368 | 0.340 | 0.392 |
| Pivot Point | 0.302 | 0.302 | 0.314 | 0.300 | 0.302 |
| Support 1 (S1) | 0.253 | 0.267 | 0.278 | 0.250 | 0.198 |
| Support 2 (S2) | 0.212 | 0.246 | 0.210 | 0.190 | |
| Support 3 (S3) | 0.163 | 0.212 | 0.183 | ||
| Support 4 (S4) | 0.160 |
